RU95106901A - Method for modeling experimental intestinal antiperistalsis - Google Patents

Method for modeling experimental intestinal antiperistalsis

Info

Publication number
RU95106901A
RU95106901A RU95106901/14A RU95106901A RU95106901A RU 95106901 A RU95106901 A RU 95106901A RU 95106901/14 A RU95106901/14 A RU 95106901/14A RU 95106901 A RU95106901 A RU 95106901A RU 95106901 A RU95106901 A RU 95106901A
Authority
RU
Russia
Prior art keywords
antiperistalsis
intestinal
modeling experimental
experimental intestinal
modeling
Prior art date
Application number
RU95106901/14A
Other languages
Russian (ru)
Other versions
RU2077076C1 (en
Inventor
В.Д. Затолокин
А.П. Симоненков
Г.В. Бугорский
И.Л. Привалова
Original Assignee
В.Д. Затолокин
А.П. Симоненков
Г.В. Бугорский
И.Л. Привалова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by В.Д. Затолокин, А.П. Симоненков, Г.В. Бугорский, И.Л. Привалова filed Critical В.Д. Затолокин
Priority to RU95106901A priority Critical patent/RU2077076C1/en
Publication of RU95106901A publication Critical patent/RU95106901A/en
Application granted granted Critical
Publication of RU2077076C1 publication Critical patent/RU2077076C1/en

Links

Abstract

FIELD: medicine, pathological physiology. SUBSTANCE: serotonin adipinate is injected into mesenteric artery of ileal distal end. EFFECT: higher efficiency. 2 dwg

Claims (1)

Способ относится к медицине, а именно к патологической физиологии, и может быть использовано при изучении периферического механизма рвоты. С целью создания модели антиперистальтики кишечника в эксперименте в брыжеечную артерию дистального конца изолированного участка подвздошной кишки вводят серотонин-адипинат.The method relates to medicine, namely to pathological physiology, and can be used to study the peripheral mechanism of vomiting. In order to create a model of intestinal antperistalsis in the experiment, serotonin-adipate is introduced into the mesenteric artery of the distal end of the isolated ileum.
RU95106901A 1995-04-28 1995-04-28 Method for modeling intestine antiperistalsis under experimental conditions RU2077076C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95106901A RU2077076C1 (en) 1995-04-28 1995-04-28 Method for modeling intestine antiperistalsis under experimental conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95106901A RU2077076C1 (en) 1995-04-28 1995-04-28 Method for modeling intestine antiperistalsis under experimental conditions

Publications (2)

Publication Number Publication Date
RU95106901A true RU95106901A (en) 1997-02-10
RU2077076C1 RU2077076C1 (en) 1997-04-10

Family

ID=20167278

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95106901A RU2077076C1 (en) 1995-04-28 1995-04-28 Method for modeling intestine antiperistalsis under experimental conditions

Country Status (1)

Country Link
RU (1) RU2077076C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2479869C1 (en) * 2011-09-20 2013-04-20 Александр Борисович Горпинич Method for stimulating intestinal antiperistalsis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2479869C1 (en) * 2011-09-20 2013-04-20 Александр Борисович Горпинич Method for stimulating intestinal antiperistalsis

Also Published As

Publication number Publication date
RU2077076C1 (en) 1997-04-10

Similar Documents

Publication Publication Date Title
BR8806397A (en) PROCESS FOR COATING A "CAPLET" WITH A GELATINOUS COATING TO PRODUCE A SIMULATED CAPSULE MEDICINE; "CAPLET" SO PRODUCED AND CAPSULE MEDICINE
MX168000B (en) DIETARY SUPPLEMENT CONTAINING BETA-GLUCAN SUPPLEMENT
ES2103468T3 (en) TREATMENT OF INTESTINAL INFLAMMATION.
ID18399A (en) PROCESS FOR MAKING SEPARATED CRYSTALS OF POLYCARBOXICATE ACID AS SEPARATED WITH REDUCED SMELL AND EXTENSIVE SHELL
EP0350036A3 (en) Topical hematoporphyrin
MY110402A (en) 6-chloro-5-fluoro-3-(2-thenoyl) -2-oxindole-1- carboxamide as an analgesic and anti-inflammatory agent
DE68924714D1 (en) USE OF ESSENTIAL FATTY ACIDS FOR THE PRODUCTION OF A MEDICINE FOR THE TREATMENT OF ECZEMAS.
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
BR9809678A (en) Triptolyte derivatives useful in the treatment of autoimmune diseases
RU95106901A (en) Method for modeling experimental intestinal antiperistalsis
DE69533311D1 (en) METHOD FOR TREATING AUTOIMMUNE DISEASES BY TYPE 1 INTERFERON
NO881629D0 (en) APPLICATION OF ANTI-ANTI-SUBSTANCES FOR TREATMENT OF DISEASES IN THE Gastro-intestinal tract.
ATE124627T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DICLOFENAC SODIUM FOR TOPICAL USE.
PT1135154E (en) IMPROVEMENT OF FOLICULOGENESE
DE3786705D1 (en) USE OF AN ORNITHIN DECARBOXYLATE INHIBITOR FOR PRODUCING A PREPARATION FOR THE TREATMENT, IN CONNECTION WITH LAK CELLS AND INTERLEUKIN-2, OF TUMORS.
RU93014328A (en) METHOD FOR OBTAINING BIOENERGY PREPARATIONS AND DEVICE FOR TRANSFERING FREQUENCY INFORMATION TO MEDIA
RU93009395A (en) METHOD OF MODELING GRAPH POSITIVE STAPHYLCOCCUS SEPSIS
NO960347D0 (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
GEU1997171Y (en) Method for Treatment of Large Intestine Constipation
RU95106870A (en) Method of creation of model of deforming arthrosis of knee joint in animals
NO952904L (en) Lysine salt of 6-chloro-5-fluoro-3- (2-tenoyl) -2-oxindole-1-carboxamide
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU94006632A (en) METHOD OF TREATING NON-SPECIFIC ULCEROUS COLITIS
RU93051917A (en) METHOD FOR TREATING ONCOLOGICAL DISEASES
RU93005463A (en) METHOD OF MODELING OF CLOSED INTRODUCTION OF CLAMPS INTO THE BODY CALL